دورية أكاديمية
Ethnic and racial differences in self-reported symptoms, health status, activity level, and missed work at 3 and 6 months following SARS-CoV-2 infection.
| العنوان: | Ethnic and racial differences in self-reported symptoms, health status, activity level, and missed work at 3 and 6 months following SARS-CoV-2 infection. |
|---|---|
| المؤلفون: | O'Laughlin KN; Department of Emergency Medicine, University of Washington, Seattle, WA, United States.; Department of Global Health, University of Washington, Seattle, WA, United States., Klabbers RE; Department of Emergency Medicine, University of Washington, Seattle, WA, United States.; Department of Global Health, University of Washington, Seattle, WA, United States., Ebna Mannan I; Center for Outcomes Research and Evaluation, Yale School of Medicine, New Haven, CT, United States., Gentile NL; Department of Family Medicine, University of Washington, Seattle, WA, United States.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States.; Post-COVID Rehabilitation and Recovery Clinic, University of Washington, Seattle, WA, United States., Geyer RE; Department of Family Medicine, University of Washington, Seattle, WA, United States., Zheng Z; Department of Family Medicine, University of Washington, Seattle, WA, United States., Yu H; Center for Outcomes Research and Evaluation, Yale School of Medicine, New Haven, CT, United States.; Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT, United States., Li SX; Center for Outcomes Research and Evaluation, Yale School of Medicine, New Haven, CT, United States., Chan KCG; Department of Biostatistics, University of Washington, Seattle, WA, United States.; Department of Health Systems and Population Health, University of Washington, Seattle, WA, United States., Spatz ES; Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT, United States.; Department of Epidemiology, Yale School of Public Health, New Haven, CT, United States.; Yale Center for Outcomes Research and Evaluation, Yale School of Medicine, New Haven, CT, United States., Wang RC; Department of Emergency Medicine, University of California San Francisco, San Francisco, CA, United States., L'Hommedieu M; Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States., Weinstein RA; Divisions of Infectious Diseases, Department of Internal Medicine, Rush University Medical Center, Chicago, IL, United States.; Department of Medicine, Cook County Hospital, Chicago, IL, United States., Plumb ID; National Center for Immunizations and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, GA, United States., Gottlieb M; Department of Emergency Medicine, Rush University Medical Center, Chicago, IL, United States., Huebinger RM; UTHealth Houston McGovern Medical School Department of Emergency Medicine, Houston, TX, United States., Hagen M; National Center for Immunizations and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, GA, United States., Elmore JG; Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States., Hill MJ; UTHealth Houston McGovern Medical School Department of Emergency Medicine, Houston, TX, United States., Kelly M; Department of Emergency Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, United States., McDonald S; Department of Emergency Medicine, University of Texas Southwestern Medical Center, Dallas, TX, United States.; Clinical Informatics Center, University of Texas Southwestern Medical Center, Dallas, TX, United States., Rising KL; Department of Emergency Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, United States.; Center for Connected Care, Thomas Jefferson University, Philadelphia, PA, United States., Rodriguez RM; Department of Emergency Medicine, University of California San Francisco, San Francisco, CA, United States., Venkatesh A; Center for Outcomes Research and Evaluation, Yale School of Medicine, New Haven, CT, United States.; Department of Emergency Medicine, Yale School of Medicine, New Haven, CT, United States., Idris AH; Department of Emergency Medicine, University of Texas Southwestern Medical Center, Dallas, TX, United States., Santangelo M; Divisions of Infectious Diseases, Department of Internal Medicine, Rush University Medical Center, Chicago, IL, United States., Koo K; Divisions of Infectious Diseases, Department of Internal Medicine, Rush University Medical Center, Chicago, IL, United States., Saydah S; National Center for Immunizations and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, GA, United States., Nichol G; Department of Emergency Medicine, University of Washington, Seattle, WA, United States., Stephens KA; Department of Family Medicine, University of Washington, Seattle, WA, United States.; Biomedical Informatics and Medical Education, University of Washington, Seattle, WA, United States. |
| مؤلفون مشاركون: | INSPIRE Group |
| المصدر: | Frontiers in public health [Front Public Health] 2024 Jan 30; Vol. 11, pp. 1324636. Date of Electronic Publication: 2024 Jan 30 (Print Publication: 2023). |
| نوع المنشور: | Multicenter Study; Journal Article; Research Support, U.S. Gov't, P.H.S.; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: Frontiers Editorial Office Country of Publication: Switzerland NLM ID: 101616579 Publication Model: eCollection Cited Medium: Internet ISSN: 2296-2565 (Electronic) Linking ISSN: 22962565 NLM ISO Abbreviation: Front Public Health Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Lausanne : Frontiers Editorial Office |
| مواضيع طبية MeSH: | COVID-19*/epidemiology, Adult ; Humans ; Self Report ; Race Factors ; COVID-19 Vaccines ; Prospective Studies ; SARS-CoV-2 ; Health Status ; White |
| مستخلص: | Introduction: Data on ethnic and racial differences in symptoms and health-related impacts following SARS-CoV-2 infection are limited. We aimed to estimate the ethnic and racial differences in symptoms and health-related impacts 3 and 6 months after the first SARS-CoV-2 infection. Methods: Participants included adults with SARS-CoV-2 infection enrolled in a prospective multicenter US study between 12/11/2020 and 7/4/2022 as the primary cohort of interest, as well as a SARS-CoV-2-negative cohort to account for non-SARS-CoV-2-infection impacts, who completed enrollment and 3-month surveys ( N = 3,161; 2,402 SARS-CoV-2-positive, 759 SARS-CoV-2-negative). Marginal odds ratios were estimated using GEE logistic regression for individual symptoms, health status, activity level, and missed work 3 and 6 months after COVID-19 illness, comparing each ethnicity or race to the referent group (non-Hispanic or white), adjusting for demographic factors, social determinants of health, substance use, pre-existing health conditions, SARS-CoV-2 infection status, COVID-19 vaccination status, and survey time point, with interactions between ethnicity or race and time point, ethnicity or race and SARS-CoV-2 infection status, and SARS-CoV-2 infection status and time point. Results: Following SARS-CoV-2 infection, the majority of symptoms were similar over time between ethnic and racial groups. At 3 months, Hispanic participants were more likely than non-Hispanic participants to report fair/poor health (OR: 1.94; 95%CI: 1.36-2.78) and reduced activity (somewhat less, OR: 1.47; 95%CI: 1.06-2.02; much less, OR: 2.23; 95%CI: 1.38-3.61). At 6 months, differences by ethnicity were not present. At 3 months, Other/Multiple race participants were more likely than white participants to report fair/poor health (OR: 1.90; 95% CI: 1.25-2.88), reduced activity (somewhat less, OR: 1.72; 95%CI: 1.21-2.46; much less, OR: 2.08; 95%CI: 1.18-3.65). At 6 months, Asian participants were more likely than white participants to report fair/poor health (OR: 1.88; 95%CI: 1.13-3.12); Black participants reported more missed work (OR, 2.83; 95%CI: 1.60-5.00); and Other/Multiple race participants reported more fair/poor health (OR: 1.83; 95%CI: 1.10-3.05), reduced activity (somewhat less, OR: 1.60; 95%CI: 1.02-2.51; much less, OR: 2.49; 95%CI: 1.40-4.44), and more missed work (OR: 2.25; 95%CI: 1.27-3.98). Discussion: Awareness of ethnic and racial differences in outcomes following SARS-CoV-2 infection may inform clinical and public health efforts to advance health equity in long-term outcomes. Competing Interests: JGE is Editor in Chief of Adult Primary Care topics for UpToDate. MG reports grant funding from the Rush Center for Emerging Infectious Diseases Research Grant, Biomedical Advanced Research and Development Authority Research Grant, Emergency Medicine Foundation/Council of Residency Directors in Emergency Medicine Education Research Grant, Emergency Medicine: Reviews and Perspectives Medical Education Research Grant, University of Ottawa Department of Medicine Education Grant; and Society of Directors of Research in Medical Education Grant. KLR reports research grant funding from Abbott Diagnostics, DermTech, MeMed, Prenosis, and Siemens Healthcare Diagnostics. RMR reports research funding for PROCOVAXED funded by NIAID R01AI166967-01 (PI: Rodriquez). KK reports HECAP funded by RWJF (contract number: 79308 PI: Ansell); Chicago Department of Public Health Order 2020–4 COVID-19 Data Sharing for Patient Safety and Capacity Management funded by CDC (contract number: 6NU50CK000556-01-04 PI: Saldanha). GN reports funding through National Institutes of Health. PROCOVAXED Trial, Site PI. Centers for Disease Control and Prevention. Clinical Core, INSPIRE Registry, PI. Patient-Centered Outcomes Research Institute, Washington, DC. University of Washington PCORNet Expansion Award, Joint PI. Abiomed Inc., Danvers, MA. Emergency Care Core for Trial of Impella in Patients with STEMI and Cardiogenic Shock (RECOVER IV), PI. ZOLL Medical Corp., Chelmsford, MA, Multidimensional Study of Oxygenation in Early Post-Resuscitation (MOSER), PI. Vapotherm Inc., Exeter, NH. Vapotherm Device for Rapid Cooling Study (VOS), Co-PI. ZOLL Circulation Inc., San Jose, CA. Better Resuscitation with Supersaturated Oxygen (BASSO) Study, Co-PI. Powerful Medical Inc., Bratislava, Slovakia, US Validation Study of AI-Enhanced Diagnosis of Occluding Myocardial Infarction, PI. CPR Therapeutics Inc., Putney, VT. Consultant. Heartbeam Inc., Santa Clara, CA. Consultant. Invero Health LLC, Montville, NJ. Consultant. Kestra Medical Technologies Inc., Kirkland, WA. Consultant. Orixha Inc., Saint Cyr Au Mont d’Or, France. Consultant. BrainCool AB, Lund, Sweden. Consultant Patent for measurement of blood flow during CPR; non-provisional patent pending for blood flow measurement during CPR using signal gating; non-provisional patent pending for reperfusion-injury modifying device; all assigned to University of Washington. KNO reports research grant funding for PROCOVOXED funded by NIAID R01 AI166967 (PI: Rodriguez). The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2024 O’Laughlin, Klabbers, Ebna Mannan, Gentile, Geyer, Zheng, Yu, Li, Chan, Spatz, Wang, L’Hommedieu, Weinstein, Plumb, Gottlieb, Huebinger, Hagen, Elmore, Hill, Kelly, McDonald, Rising, Rodriguez, Venkatesh, Idris, Santangelo, Koo, Saydah, Nichol, Stephens and the INSPIRE Group.) |
| References: | Am J Prev Med. 2008 Jan;34(1):16-22. (PMID: 18083446) Public Health. 2020 Dec;189:129-134. (PMID: 33227595) JAMA. 2021 Feb 16;325(7):623-624. (PMID: 33492329) MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464. (PMID: 32298251) Patient. 2022 Nov;15(6):715-728. (PMID: 35907120) Health Serv Res. 2009 Dec;44(6):2093-105. (PMID: 19732170) Arch Phys Med Rehabil. 2023 Jan;104(1):11-17. (PMID: 36202227) JAMA Netw Open. 2022 Oct 3;5(10):e2238804. (PMID: 36301542) J Urban Health. 2016 Jun;93(3):456-67. (PMID: 27193595) J Autoimmun. 2023 Feb;135:102991. (PMID: 36634460) J Gen Intern Med. 2022 Jun;37(8):1988-1995. (PMID: 35391623) MMWR Morb Mortal Wkly Rep. 2020 Oct 23;69(42):1522-1527. (PMID: 33090978) Health Aff (Millwood). 2023 Mar;42(3):433-442. (PMID: 36877912) Open Forum Infect Dis. 2023 Feb 01;10(2):ofad047. (PMID: 36846611) Ann Intern Med. 2021 Mar;174(3):362-373. (PMID: 33253040) Lancet Reg Health Am. 2023 Feb 28;19:100464. (PMID: 36915389) Nature. 2021 Jan;589(7840):82-87. (PMID: 33171481) Am J Prev Med. 2006 Apr;30(4):333-9. (PMID: 16530621) J Gen Intern Med. 2023 Apr;38(5):1127-1136. (PMID: 36795327) PLoS One. 2022 Mar 3;17(3):e0264260. (PMID: 35239680) Nat Commun. 2021 Nov 12;12(1):6571. (PMID: 34772922) JAMA Intern Med. 2021 Jan 1;181(1):131-134. (PMID: 32804192) J Hum Cap. 2013 Winter;7(4):378-410. (PMID: 25632311) Health Secur. 2021 Jun;19(S1):S14-S26. (PMID: 34076499) Environ Res. 2006 Oct;102(2):181-96. (PMID: 16828737) MMWR Morb Mortal Wkly Rep. 2021 Apr 16;70(15):560-565. (PMID: 33857068) J Psychosom Res. 2006 Feb;60(2):113-24. (PMID: 16439263) JAMA Netw Open. 2021 Nov 1;4(11):e2134147. (PMID: 34762110) Arch Intern Med. 2009 Oct 12;169(18):1698-704. (PMID: 19822827) J Infect Dis. 2022 Nov 1;226(9):1593-1607. (PMID: 35429399) J Acquir Immune Defic Syndr. 2021 Feb 1;86(2):200-207. (PMID: 33196555) Clin Infect Dis. 2023 Jun 8;76(11):1930-1941. (PMID: 36705268) J R Soc Med. 2023 Aug;116(8):263-273. (PMID: 37164035) Public Health Rep. 2001 Sep-Oct;116(5):404-16. (PMID: 12042604) Annu Rev Public Health. 2001;22:309-35. (PMID: 11274524) Annu Rev Clin Psychol. 2015;11:407-40. (PMID: 25581238) J Natl Med Assoc. 2023 Apr;115(2):233-243. (PMID: 36792456) Prev Med. 2023 Apr;169:107461. (PMID: 36813250) Health Expect. 2023 Feb;26(1):542-554. (PMID: 36512382) PM R. 2021 Sep;13(9):1027-1043. (PMID: 34346558) JAMA. 2020 Jun 23;323(24):2466-2467. (PMID: 32391864) Am J Prev Med. 2007 Oct;33(4 Suppl):S240-5. (PMID: 17884571) Int J Equity Health. 2021 Nov 24;20(1):248. (PMID: 34819081) |
| فهرسة مساهمة: | Keywords: COVID-19; SARS-CoV-2; cohort; disparities; ethnicity; race; survey |
| المشرفين على المادة: | 0 (COVID-19 Vaccines) |
| تواريخ الأحداث: | Date Created: 20240214 Date Completed: 20240215 Latest Revision: 20240507 |
| رمز التحديث: | 20240507 |
| مُعرف محوري في PubMed: | PMC10861779 |
| DOI: | 10.3389/fpubh.2023.1324636 |
| PMID: | 38352132 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2296-2565 |
|---|---|
| DOI: | 10.3389/fpubh.2023.1324636 |